Work

A phase I trial of GRN163L (GRN), a first-in-class telomerase inhibitor, in advanced solid tumors

Year: 2008

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2008.26.15_suppl.3581

Authors: M. J. Ratain, F. M. Benedetti, L. Janisch, S. Khor, R. L. Schilsky, E. E. Cohen, M. L. Maitland, L. Elias, P. M. LoRusso

Language: English

Topic: Telomeres, Telomerase, and Senescence

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2524744840

Cites:

Cited by: 8

Related to: 10